Search research articles
Contact Us
Filters
Showing results (291-300 of 377) with videos related to
Page
of 38
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
December 4, 2013
Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients
Matthias M Heck, Michael Souvatzoglou, Margitta Retz, et al.
European Urology
|
July 6, 2023
Prostate-specific Membrane Antigen Reporting and Data System Version 2.0
Rudolf A Werner, Philipp E Hartrampf, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 20, 2025
PSMA-Directed PET/MRI Enables Noninvasive Diagnosis and Prognosis in Patients with Increased PSA Levels: Results from the Prospective Randomized RAPID Trial
Markus Hartenbach, Sazan Rasul, Bernhard Grubmüller, et al.
The American Journal of Surgical Pathology
|
May 29, 2007
Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract
Matthias Eiber, Johanna M M van Oers, Ellen C Zwarthoff, et al.
European Urology
|
June 14, 2020
Efficacy and Safety of <sup>177</sup>Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study
Andrei Gafita, Wolfgang P Fendler, Wang Hui, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 26, 2018
Detection Efficacy of <sup>18</sup>F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Frederik L Giesel, Karina Knorr, Fabian Spohn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 7, 2019
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET
Andrea Farolfi, Harun Ilhan, Andrei Gafita, et al.
European Urology
|
April 17, 2019
Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer
Thomas Horn, Markus Krönke, Isabel Rauscher, et al.
Molecular Therapy Oncolytics
|
December 2, 2022
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma
Rebekka Spellerberg, Teoman Benli-Hoppe, Carolin Kitzberger, et al.
The Journal of Experimental Medicine
|
November 30, 2017
Correction: Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
Charalambos Kaittanis, Chrysafis Andreou, Haley Hieronymus, et al.
Page
of 38
Search research articles
Search
Showing results (291-300 of 377) with videos related to
Sort By:
Page
of 38
European Journal of Nuclear Medicine and Molecular Imaging
|
December 4, 2013
Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients
Matthias M Heck, Michael Souvatzoglou, Margitta Retz, et al.
European Urology
|
July 6, 2023
Prostate-specific Membrane Antigen Reporting and Data System Version 2.0
Rudolf A Werner, Philipp E Hartrampf, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 20, 2025
PSMA-Directed PET/MRI Enables Noninvasive Diagnosis and Prognosis in Patients with Increased PSA Levels: Results from the Prospective Randomized RAPID Trial
Markus Hartenbach, Sazan Rasul, Bernhard Grubmüller, et al.
The American Journal of Surgical Pathology
|
May 29, 2007
Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract
Matthias Eiber, Johanna M M van Oers, Ellen C Zwarthoff, et al.
European Urology
|
June 14, 2020
Efficacy and Safety of <sup>177</sup>Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study
Andrei Gafita, Wolfgang P Fendler, Wang Hui, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 26, 2018
Detection Efficacy of <sup>18</sup>F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Frederik L Giesel, Karina Knorr, Fabian Spohn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 7, 2019
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET
Andrea Farolfi, Harun Ilhan, Andrei Gafita, et al.
European Urology
|
April 17, 2019
Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer
Thomas Horn, Markus Krönke, Isabel Rauscher, et al.
Molecular Therapy Oncolytics
|
December 2, 2022
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma
Rebekka Spellerberg, Teoman Benli-Hoppe, Carolin Kitzberger, et al.
The Journal of Experimental Medicine
|
November 30, 2017
Correction: Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
Charalambos Kaittanis, Chrysafis Andreou, Haley Hieronymus, et al.
Page
of 38